EUVIMEDEUVIMED entdecken
Crossref

Testing positive after genetic testing for hereditary cancer: whatÓ?s next?

Carolina Carvalho, Diana Simão, Fátima Vaz, Gabriela Sousa, Graça Freitas, Isadora Rosa, Isália Miguel, João Silva, Luzia Garrido, Maria Almeida, Miguel Ornelas-Azevedo, Paula Rodrigues und 7 weitere

Revista Portuguesa Oncologia · 2025

DOI: 10.24875/rpo.25000008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Portuguesa Oncologia, 2025. Verfasst von Carolina Carvalho und 18 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The growing integration of genetic testing into clinical oncology practice has led to the identification of a growing number of individuals carrying pathogenic variants associated with hereditary cancer.

Objectives

These cases require a multidisciplinary and personalized approach; however, access to structured follow-up care remains unstandardized in Portugal.

Methods

To discuss existing organizational models and establish consensus on an optimal infrastructure, the Hereditary Cancer Group of the Portuguese Society of Oncology organized a workshop in September 2023, involving representatives from various healthcare units across the country.

Results

This document, arising from that meeting, proposes the implementation of a structured follow-up model for individuals at genetic risk of cancer.It aims to ensure equitable access to specialized care and to strengthen collaboration with General and Family Medicine.This coordination faces significant challenges, including the transmission of genetic information and limited access to imaging prescriptions, such as magnetic resonance imaging.Despite advances in molecular testing for hereditary cancer diagnosis, the clinical follow-up infrastructure -particularly in terms of multidisciplinary teams, genetic information management, equipment availability, and human resources -has not kept pace.Nevertheless, several centers have begun establishing multidisciplinary teams comprising various medical specialties, specialized nurses, and other health professionals who play a key role in managing patients' care pathways.A central priority is to define the role of the case navigator and ensure continuous patient contact throughout the care journey.This document presents a set of proposals aimed at fostering care organization and integration, technological solutions, the implementation of case navigators, and the dissemination of updates from European reference networks nationwide.

Zitieren

APA

Carvalho, C., Simão, D., Vaz, F., Sousa, G., Freitas, G., Rosa, I., Miguel, I., Silva, J., Garrido, L., Almeida, M., Ornelas-Azevedo, M., Rodrigues, P., Souteiro, P., Neto-Silva, R., Bento, S., Silva-Soares, S., Câmara, S., Costa, S., & Milagre, T. (2025). Testing positive after genetic testing for hereditary cancer: whatÓ?s next?. Revista Portuguesa Oncologia. https://doi.org/10.24875/rpo.25000008

Vancouver

Carvalho C, Simão D, Vaz F, Sousa G, Freitas G, Rosa I, et al. Testing positive after genetic testing for hereditary cancer: whatÓ?s next?. Revista Portuguesa Oncologia. 2025. doi:10.24875/rpo.25000008

BibTeX
@article{Carvalho2025,
  author = {Carvalho, Carolina and Simão, Diana and Vaz, Fátima and Sousa, Gabriela and Freitas, Graça and Rosa, Isadora and Miguel, Isália and Silva, João and Garrido, Luzia and Almeida, Maria and Ornelas-Azevedo, Miguel and Rodrigues, Paula and Souteiro, Pedro and Neto-Silva, Rosa and Bento, Sandra and Silva-Soares, Sandra and Câmara, Sara and Costa, Susy and Milagre, Tamara},
  title = {Testing positive after genetic testing for hereditary cancer: whatÓ?s next?},
  journal = {Revista Portuguesa Oncologia},
  year = {2025},
  doi = {10.24875/rpo.25000008}
}
Kostenlos starten →